Compounds having phosphorodithioate linkages of high chiral purity
AssigneeIsis Pharmaceuticals, Inc.
InventorsPhillip D. Cook, Glenn Hoke
Life of this patent
Estimating the term…
Abstract
Sequence-specific phosphorothioate oligonucleotides comprising nucleoside units which are joined together by either substantially all Sp or substantially all Rp phosphorothioate intersugar linkages are provided. Such sequence-specific phosphorothioate oligonucleotides having substantially chirally pure intersugar linkages are prepared by enzymatic or chemical synthesis. Sequence-specific phosphorodithioate oligonucleotides are also provided. Such sequence-specific phosphorodithioate oligonucleotides are prepared by chemical synthesis. They are especially well suited as diagnostics, therapeutics and research reagents.
Claims8
An oligonucleotide represented by SEQ ID NO:1 wherein at least 75% of the nucleoside units are joined together by Sp phosphorothioate 3' to 5' linkages.
An oligonucleotide represented by SEQ ID NO:1 wherein at least 75% of the nucleoside units are joined together by Rp phosphorothioate 3' to 5' linkages.
An oligonucleotide represented by SEQ ID NO:1 wherein all of the nucleoside units are joined together by phosphorodithioate 3' to 5' linkages.
Dependencies are inferred from the claim text.